OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
377
Results
Show all
Save search
Copy query
Show results for
Unknown
(372)
Transcriptomics
(2)
Genomics
(1)
Proteomics
(1)
Metabolomics
(1)
Organisms
Homo sapiens
(2)
Mus musculus
(1)
Repository
biostudies-arrayexpress
(2)
EGA
(1)
MassIVE
(1)
MetaboLights
(1)
Technology Type
NMR spectroscopy
(1)
Instrument Platform
Q Exactive
(1)
Nuclear Magnetic Resonance (NMR)
(1)
Publication Date
2011
(2)
2017
(1)
2021
(1)
CHEBI ID
CHEBI:132950
(1)
CHEBI:16997
(1)
CHEBI:17790
(1)
CHEBI:18139
(1)
CHEBI:32805
(1)
CHEBI:132966
(1)
CHEBI:91315
(1)
CHEBI:22660
(1)
CHEBI:28300
(1)
CHEBI:26271
(1)
CHEBI:15366
(1)
CHEBI:16449
(1)
CHEBI:26986
(1)
CHEBI:24898
(1)
CHEBI:18186
(1)
CHEBI:78320
(1)
CHEBI:27570
(1)
CHEBI:9349
(1)
CHEBI:32806
(1)
CHEBI:27266
(1)
CHEBI:28044
(1)
CHEBI:16811
(1)
CHEBI:17234
(1)
CHEBI:25017
(1)
CHEBI:17822
(1)
CHEBI:30794
(1)
CHEBI:17497
(1)
CHEBI:27480
(1)
CHEBI:5855
(1)
CHEBI:16354
(1)
Metabolite Name
Methylsuccinate
(1)
Tartrate
(1)
N-Methylhydantoin
(1)
Trimethylamine
(1)
N-Phenylacetylglycine
(1)
Guanidoacetate
(1)
3-Indoxylsulfate
(1)
3-Hydroxyisovalerate
(1)
2-Hydroxyisobutyrate
(1)
Formate
(1)
Trans-Aconitate
(1)
Methanol
(1)
Acetate
(1)
Hippurate
(1)
Tyrosine
(1)
Lactate
(1)
Valine
(1)
Glycolate
(1)
Histidine
(1)
Alanine
(1)
Ibuprofen
(1)
N,N-Dimethylglycine
(1)
Ethanol
(1)
Glycine
(1)
Choline
(1)
Dimethylamine
(1)
Acetone
(1)
Propylene glycol
(1)
Urea
(1)
Trimethylamine N-oxide
(1)
Study type
Transcription profiling by array
(2)
Release Date
2022
(54)
2021
(50)
2025
(46)
2024
(36)
2023
(36)
2018
(33)
2020
(26)
2017
(20)
2019
(17)
2016
(17)
2015
(12)
2026
(6)
2011
(5)
2014
(5)
2013
(4)
2009
(3)
2010
(2)
2012
(1)
2007
(1)
Previous
page
1 / 38
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
38
Next
page
Sort
by:
Relevance
Page size
10
A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma.
Not available
S-EPMC8163735
|
biostudies-literature
Cite
BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.
Not available
S-EPMC7603509
|
biostudies-literature
Cite
Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.
Not available
S-EPMC5931084
|
biostudies-literature
Cite
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.
Not available
S-EPMC5490236
|
biostudies-literature
Cite
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.
Not available
S-EPMC8786898
|
biostudies-literature
Cite
Use of magnetic resonance imaging-guided radiotherapy for breast cancer: a scoping review protocol.
Not available
S-EPMC7852080
|
biostudies-literature
Cite
Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistry.
Not available
S-EPMC9843255
|
biostudies-literature
Cite
Identifying and targeting determinants of melanoma cellular invasion.
Not available
S-EPMC5173051
|
biostudies-literature
Cite
Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Not available
S-EPMC5112703
|
biostudies-literature
Cite
Perspective: cancer vaccines in the era of immune checkpoint blockade.
Not available
S-EPMC6267701
|
biostudies-literature
Cite
Previous
page
1 / 38
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
38
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
